AU2002250254A1 - Nucleic acids, proteins, and antibodies - Google Patents
Nucleic acids, proteins, and antibodiesInfo
- Publication number
- AU2002250254A1 AU2002250254A1 AU2002250254A AU2002250254A AU2002250254A1 AU 2002250254 A1 AU2002250254 A1 AU 2002250254A1 AU 2002250254 A AU2002250254 A AU 2002250254A AU 2002250254 A AU2002250254 A AU 2002250254A AU 2002250254 A1 AU2002250254 A1 AU 2002250254A1
- Authority
- AU
- Australia
- Prior art keywords
- antibodies
- proteins
- nucleic acids
- nucleic
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27421401P | 2001-03-09 | 2001-03-09 | |
US60/274,214 | 2001-03-09 | ||
PCT/US2002/006990 WO2002072763A2 (en) | 2001-03-09 | 2002-03-08 | Nucleic acids, proteins, and antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002250254A1 true AU2002250254A1 (en) | 2002-09-24 |
Family
ID=23047270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002250254A Abandoned AU2002250254A1 (en) | 2001-03-09 | 2002-03-08 | Nucleic acids, proteins, and antibodies |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002250254A1 (en) |
WO (1) | WO2002072763A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4242607B2 (en) * | 2002-07-04 | 2009-03-25 | 学校法人北里研究所 | Feline infectious peritonitis vaccine |
AU2005319306B9 (en) * | 2004-12-22 | 2012-04-05 | Alnylam Pharmaceuticals, Inc. | Conserved HBV and HCV sequences useful for gene silencing |
JOP20200092A1 (en) | 2014-11-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF |
US11324820B2 (en) | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
WO2020036862A1 (en) | 2018-08-13 | 2020-02-20 | Alnylam Pharmaceuticals, Inc. | HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003527105A (en) * | 1999-12-22 | 2003-09-16 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | NK cell receptor polynucleotides, polypeptides, and antibodies |
-
2002
- 2002-03-08 AU AU2002250254A patent/AU2002250254A1/en not_active Abandoned
- 2002-03-08 WO PCT/US2002/006990 patent/WO2002072763A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002072763A3 (en) | 2003-02-27 |
WO2002072763A2 (en) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001241407A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2002250254A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001229508A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237950A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001230958A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241419A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001243137A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001247190A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241411A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001236460A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001236459A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241403A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239728A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239726A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237953A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237948A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237946A1 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |